251 related articles for article (PubMed ID: 33764188)
1. Competing Causes of Death in Older Adults with Thyroid Cancer.
Papaleontiou M; Norton EC; Reyes-Gastelum D; Banerjee M; Haymart MR
Thyroid; 2021 Sep; 31(9):1359-1365. PubMed ID: 33764188
[No Abstract] [Full Text] [Related]
2. Population-based study evaluating and predicting the probability of death resulting from thyroid cancer and other causes among patients with thyroid cancer.
Yang L; Shen W; Sakamoto N
J Clin Oncol; 2013 Feb; 31(4):468-74. PubMed ID: 23270002
[TBL] [Abstract][Full Text] [Related]
3. Competing Risk of Death in Elderly Patients with Newly Diagnosed Stage I Breast Cancer.
Wasif N; Neville M; Gray R; Cronin P; Pockaj BA
J Am Coll Surg; 2019 Jul; 229(1):30-36.e1. PubMed ID: 30930100
[TBL] [Abstract][Full Text] [Related]
4. Cause-specific mortality after diagnosis of thyroid cancer: a large population-based study.
Du B; Wang F; Wu L; Wang Z; Zhang D; Huang Z; Gao L; Li Y; Liang C; Li P; Yao R
Endocrine; 2021 Apr; 72(1):179-189. PubMed ID: 32770440
[TBL] [Abstract][Full Text] [Related]
5. Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Mazzaferri EL; Jhiang SM
Am J Med; 1994 Nov; 97(5):418-28. PubMed ID: 7977430
[TBL] [Abstract][Full Text] [Related]
6. Competing-Risks Model for Predicting the Postoperative Prognosis of Patients with Papillary Thyroid Adenocarcinoma Based on The Surveillance, Epidemiology, and End Results (SEER) Database.
Bian F; Li C; Han D; Xu F; Lyu J
Med Sci Monit; 2020 Jul; 26():e924045. PubMed ID: 32710734
[TBL] [Abstract][Full Text] [Related]
7. Prognostic indicators in well-differentiated thyroid carcinoma when controlling for stage and treatment.
Krook KA; Fedewa SA; Chen AY
Laryngoscope; 2015 Apr; 125(4):1021-7. PubMed ID: 25583017
[TBL] [Abstract][Full Text] [Related]
8. Impact of comorbidity on survival among men with localized prostate cancer.
Albertsen PC; Moore DF; Shih W; Lin Y; Li H; Lu-Yao GL
J Clin Oncol; 2011 Apr; 29(10):1335-41. PubMed ID: 21357791
[TBL] [Abstract][Full Text] [Related]
9. Death from thyroid cancer of follicular cell origin.
Wu HS; Young MT; Ituarte PH; D'Avanzo A; Duh QY; Greenspan FS; Loh KC; Clark OH
J Am Coll Surg; 2000 Dec; 191(6):600-6. PubMed ID: 11129807
[TBL] [Abstract][Full Text] [Related]
10. Evaluating overall survival and competing risks of death in patients with localized renal cell carcinoma using a comprehensive nomogram.
Kutikov A; Egleston BL; Wong YN; Uzzo RG
J Clin Oncol; 2010 Jan; 28(2):311-7. PubMed ID: 19933918
[TBL] [Abstract][Full Text] [Related]
11. Treatment Variation in Older Adults With Differentiated Thyroid Cancer.
Sutton W; Canner JK; Segev DL; Zeiger MA; Mathur A
J Surg Res; 2020 Oct; 254():154-164. PubMed ID: 32445931
[TBL] [Abstract][Full Text] [Related]
12. Incidence and Survival in Reproductive-Aged Women with Differentiated Thyroid Cancer: United States SEER 18 2000-2016.
Douglas EH; Rhoads A; Thomas A; Aloi J; Suhl J; Lycan T; Oleson J; Conway KM; Klubo-Gwiezdzinska J; Lynch CF; Romitti PA
Thyroid; 2020 Dec; 30(12):1781-1791. PubMed ID: 32394796
[No Abstract] [Full Text] [Related]
13. Population-Based Assessment of Complications Following Surgery for Thyroid Cancer.
Papaleontiou M; Hughes DT; Guo C; Banerjee M; Haymart MR
J Clin Endocrinol Metab; 2017 Jul; 102(7):2543-2551. PubMed ID: 28460061
[TBL] [Abstract][Full Text] [Related]
14. Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
Roche AM; Fedewa SA; Shi LL; Chen AY
Cancer; 2018 Apr; 124(8):1780-1790. PubMed ID: 29409119
[TBL] [Abstract][Full Text] [Related]
15. Providing clinicians and patients with actual prognosis: cancer in the context of competing causes of death.
Howlader N; Mariotto AB; Woloshin S; Schwartz LM
J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):255-64. PubMed ID: 25417239
[TBL] [Abstract][Full Text] [Related]
16. Disparities in cause-specific mortality by race and sex among bladder cancer patients from the SEER database.
Shu TD; Schumacher FR; Conroy B; Ponsky L; Mahran A; Bukavina L; Calaway A; Markt SC
Cancer Causes Control; 2023 Jun; 34(6):521-531. PubMed ID: 36882598
[TBL] [Abstract][Full Text] [Related]
17. The Benefit of Primary Tumor Surgical Resection in Distant Metastatic Carcinomas of the Thyroid.
Elsamna ST; Suri P; Mir GS; Roden DF; Paskhover B
Laryngoscope; 2021 May; 131(5):1026-1034. PubMed ID: 32865854
[TBL] [Abstract][Full Text] [Related]
18. Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
Lim H; Devesa SS; Sosa JA; Check D; Kitahara CM
JAMA; 2017 Apr; 317(13):1338-1348. PubMed ID: 28362912
[TBL] [Abstract][Full Text] [Related]
19. Optimal Cutoff Age for Predicting Mortality Associated with Differentiated Thyroid Cancer.
Kim SJ; Myong JP; Suh H; Lee KE; Youn YK
PLoS One; 2015; 10(6):e0130848. PubMed ID: 26102084
[TBL] [Abstract][Full Text] [Related]
20. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X
Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
